Concepedia

Publication | Open Access

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

DOIFull Paper Access

65

Citations

47

References

2018

Year

Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Supinya Iamsawat, Gabriela Andrejeva, Libia A. Luevano, Melissa M. Wolf, Uday Baliga, Carsten Krieg, Craig C. Beeson,
Clinical Cancer Research

Abstract

This study highlights the potential therapeutic significance of combinatorial strategies where ACT and inhibition of signaling kinase with checkpoint blockade could improve tumor control.

References

YearCitations

Page 1